Trial Profile
A randomised, double-blinded, placebo-controlled, cross-over trial assessing effects of 4 weeks of oral supplementation of quercetin in healthy males.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2016
Price :
$35
*
At a glance
- Drugs Quercetin (Primary)
- Indications Hyperuricaemia
- Focus Pharmacodynamics
- 25 Jul 2016 New trial record